journal
MENU ▼
Read by QxMD icon Read
search

Health Economics, Policy, and Law

journal
https://www.readbyqxmd.com/read/28482945/the-effect-of-universal-health-insurance-for-children-in-vietnam
#1
Binh T Nguyen, Anthony T Lo Sasso
Our research investigates the effects of the 2005 universal health insurance program for children under age 6 in Vietnam on health care utilization, household out-of-pocket (OOP) spending and self-reported health outcomes using data from the Vietnam Household Living Standard Survey in 2002-2004-2006-2008. We use difference-in-differences to compare children eligible for the program to older children who are ineligible for the program. Results indicate that the program increased insurance coverage by 250% for children age 0-5 relative to the pre-policy period...
May 9, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28462750/health-equality-social-justice-and-the-poverty-of-autonomy
#2
Christopher Newdick
How does the concept of autonomy assist public responses to 'lifestyle' diseases? Autonomy is fundamental to bioethics, but its emphasis on self-determination and individuality hardly supports public health policies to eat and drink less and take more exercise. Autonomy rejects a 'nanny' state. Yet, the cost of non-communicable diseases is increasing to individuals personally and to public health systems generally. Health care systems are under mounting and unsustainable pressure. What is the proper responsibility of individuals, governments and corporate interests working within a global trading environment? When public health care resources are unlikely to increase, we cannot afford to be so diffident to the cost of avoidable diseases...
May 2, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28462745/the-efficiency-of-the-local-health-systems-investigating-the-roles-of-health-administrations-and-health-care-providers
#3
Laura Anselmi, Mylène Lagarde, Kara Hanson
The analysis of efficiency in health care has largely focussed either on individual health care providers, or on sub-national health systems conceived as a unique decision-making unit. However, in hierarchically organized national health services, two separate entities are responsible for turning financial resources into services at the local level: health administrations and health care providers. Their separate roles and the one of health administrations in particular have not been explicitly considered in efficiency analysis...
May 2, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28446256/innovation-informed-consent-health-research-and-the-supreme-court-montgomery-v-lanarkshire-a-brave-new-world
#4
Jean V McHale
The Supreme Court decision in Montgomery v Lanarkshire ([2015] UKSC11) has been hailed as a landmark not least because the Court enshrines the doctrine of informed consent formally into English law for the first time in relation to medical treatment. This paper explores the decision in Montgomery. It examines what its implications may be in the future for the consent process in relation to health research and innovative treatment and whether it may prove a watershed moment leading to changing dialogues and expectations in relation to consent...
April 27, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28443522/legal-and-organisational-innovation-in-the-italian-pharmacy-system-commercial-vs-public-interest
#5
Alceste Santuari
Pharmacy services are undoubtedly an important part of primary care. Pharmacists are entrepreneurs and simultaneously they are entrusted with a public mission in the health care sector. Pharmacies then reflect a contrast between a commercial/economic objective and public interest, which is to be identified with citizens' universal right to health care services. This is the reason why in Italy, as in many other EU countries, pharmacies supply their services according to a prior authorisation granted by public authorities...
April 26, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28416025/healthcare-innovation-and-patent-law-s-pharmaceutical-privilege-is-there-a-pharmaceutical-privilege-and-if-so-should-we-remove-it
#6
Graham Dutfield
This article reviews current trends in patent claims regarding personalised, stratified and precision medicine. These trends are not particularly well understood by policymakers, even less by the public, and are quite recent. Consequently, their implications for the public interest have hardly been thought out. Some see personalised and other secondary drug patent claims as promoting better targeted treatment. Others are inclined to see them as \manifestations of 'evergreening' whereby companies are, in some cases quite cynically, trying to extend market monopolies in old products or creating new monopolies based on supposedly improved versions of such earlier drugs...
April 18, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28414005/health-care-and-health-innovation-in-europe-regulating-for-public-benefit-or-for-commercial-profit
#7
Amanda Warren-Jones
No abstract text is available yet for this article.
April 17, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28414003/regulatory-theory-commercially-sustainable-markets-rely-upon-satisfying-the-public-interest-in-obtaining-credible-goods
#8
Amanda Warren-Jones
Regulatory theory is premised on the failure of markets, prompting a focus on regulators and industry from economic perspectives. This article argues that overlooking the public interest in the sustainability of commercial markets risks markets failing completely. This point is exemplified through health care markets - meeting an essential need - and focuses upon innovative medicines as the most desired products in that market. If this seemingly invulnerable market risks failure, there is a pressing need to consider the public interest in sustainable markets within regulatory literature and practice...
April 17, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28382886/outsourcing-day-surgery-to-private-for-profit-hospitals-the-price-effects-of-competitive-tendering
#9
Terje P Hagen, Geir Hiller Holom, Kebebew N Amayu
Setting prices for elective patient treatments in private for-profit (PFP) hospitals in traditional tax-funded health systems is challenging since both the organisation of these hospitals and the tasks they perform differ considerably from what we find in public hospitals. From the year 2000, Norway became one of a few countries to gradually implement a procurement system based on competitive tendering when outsourcing elective surgery. In this study we analyse the effect of introducing competitive tendering on the prices paid to PFP hospitals...
April 6, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28345498/the-effects-of-payments-for-pharmaceuticals-a-systematic-literature-review
#10
Katarzyna Kolasa, Marta Kowalczyk
The existence of different forms of out-of-pocket payments (OOPs) for pharmaceuticals across the globe provokes the question whether they can achieve more negative or positive consequences. A systematic literature review was conducted to assess the association between drug cost sharing and health care services utilization, health care costs as well as health outcomes. Studies published in The Cochrane Library, PubMed, Embase were searched with such keywords as: drug, pharmaceutical, cost sharing, out of pocket, co-payments paired with the following: impact, health outcomes, health care costs and utilization...
March 27, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28322184/the-norwegian-national-council-for-priority-setting-in-health-care-decisions-and-justifications
#11
Gry Wester, Berit Bringedal
Different countries have adopted different strategies for tackling the challenge of allocating scarce health care resources fairly. Norway is one of the countries that has pioneered the effort to resolve priority setting by using a core set of priority-setting criteria. While the criteria themselves have been subject to extensive debate and numerous revisions, the question of how the criteria have been applied in practice has received less attention. In this paper, we examine how the criteria feature in the decisions and justifications of the Norwegian National Council for Priority Setting in Health Care, which has played an active role in deliberating about health care provision and coverage in Norway...
March 21, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28294093/identifying-health-system-value-dimensions-more-than-health-gain
#12
Joan Costa-Font, Azusa Sato, Joan Rovira Forns
Publicly funded health system reforms increasingly require the evaluation of competing programmes. However, programmes are made of multi-dimensional attributes of value (where value refers to latent expectations of health system improvement). This paper identifies the design, implementation and validation of a methodology to elicit health system values to guide health care priority setting. The exercise suggests that the proposed methodology is suitable for eliciting and validating health system values, and its findings show that pursuing health gain alone does not fully capture the dimensions of health system value...
March 15, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28290918/health-plan-choice-in-the-netherlands-restrictive-health-plans-preferred-by-young-and-healthy-individuals
#13
Romy E Bes, Emile C Curfs, Peter P Groenewegen, Judith D de Jong
In a health care system based on managed competition, health insurers negotiate on quality and price with care providers and are allowed to offer restrictive health plans. It is crucial that enrolees who need care choose restrictive health plans, as otherwise health insurers cannot channel patients to contracted providers and they will lose their bargaining power in negotiations with providers. We aim to explain enrolees' choice of a restrictive health plan in exchange for a lower premium. In 2014 an online survey with an experimental design was conducted on members of an access panel (response 78%; n=3,417)...
March 14, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28249636/adopting-new-medical-technologies-in-russian-hospitals-what-causes-inefficiency-qualitative-study
#14
Sergey Shishkin, Liudmila Zasimova
The adoption of new medical technologies often generates losses in efficiency associated with the excess or insufficient acquisition of new equipment, an inappropriate choice (in terms of economic and clinical parameters) of medical equipment, and its poor use. Russia is a good example for exploring the problem of the ineffective adoption of new medical technologies due to the massive public investment in new equipment for medical institutions in 2006-2013. This study examines the procurement of new technologies in Russian hospitals to find the main causes of inefficiency...
March 2, 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332466/towards-a-coherent-global-framework-for-health-financing-recommendations-and-recent-developments
#15
Trygve Ottersen, Riku Elovainio, David B Evans, David McCoy, Di Mcintyre, Filip Meheus, Suerie Moon, Gorik Ooms, John-Arne Røttingen
The articles in this special issue have demonstrated how unprecedented transitions have come with both challenges and opportunities for health financing. Against the background of these challenges and opportunities, the Working Group on Health Financing at the Chatham House Centre on Global Health Security laid out, in 2014, a set of policy responses encapsulated in 20 recommendations for how to make progress towards a coherent global framework for health financing. These recommendations pertain to domestic financing of national health systems, global public goods for health, external financing for national health systems and the cross-cutting issues of accountability and agreement on a new global framework...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332465/the-challenge-of-middle-income-countries-to-development-assistance-for-health-recipients-funders-both-or-neither
#16
Trygve Ottersen, Suerie Moon, John-Arne Røttingen
Recent developments have transformed the role and characteristics of middle-income countries (MICs). Many stakeholders now question the appropriate role of MICs in the system of development assistance for health (DAH), and key funders have already recast their approach to these countries. The pressing question is whether MICs should be recipients, funders, both or neither. The answer has deep implications for individual countries and their citizens, and for the DAH system as a whole. We clarify the fundamental issues involved and emphasise a special feature of many MICs: mid-level gross national income per capita (GNIpc) combined with substantial health needs and large inequalities...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332464/distributing-development-assistance-for-health-simulating-the-implications-of-11-criteria
#17
Trygve Ottersen, Suerie Moon, John-Arne Røttingen
After years of unprecedented growth in development assistance for health (DAH), the DAH system is challenged on several fronts: by the economic downturn and stagnation of DAH, by the epidemiological transition and increase in non-communicable diseases and by the economic transition and rise of the middle-income countries. Central to any potent response is a fair and effective allocation of DAH across countries. A myriad of criteria has been proposed or is currently used, but there have been no comprehensive assessment of their distributional implications...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332463/development-assistance-for-health-critiques-proposals-and-prospects-for-change
#18
Suerie Moon, Oluwatosin Omole
After a 'golden age' of extraordinary growth in the level of development assistance for health (DAH) since 1990, funding seems to have reached a plateau. With the launch of the Sustainable Development Goals, debate has intensified regarding what international financing for health should look like in the post-2015 era. In this review paper, we offer a systematic overview of problems and proposals for change. Major critiques of the current DAH system include: that the total volume of financing is inadequate; financial flows are volatile and uncertain; DAH may not result in additional resources for health; too small a proportion of DAH is transferred to recipient countries; inappropriate priority setting; inadequate coordination; weak mechanisms for accountability; and disagreement on the rationale for DAH...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332462/development-assistance-for-health-what-criteria-do-multi-and-bilateral-funders-use
#19
Trygve Ottersen, Aparna Kamath, Suerie Moon, Lene Martinsen, John-Arne Røttingen
After years of unprecedented growth in development assistance for health (DAH), the system is challenged on several fronts: by the economic downturn and stagnation of DAH, by the epidemiological transition and increase in non-communicable diseases, and by the economic transition and rise of the middle-income countries. This raises questions about which countries should receive DAH and how much, and, fundamentally, what criteria that promote fair and effective allocation. Yet, no broad comparative assessment exists of the criteria used today...
April 2017: Health Economics, Policy, and Law
https://www.readbyqxmd.com/read/28332461/global-public-goods-for-health-weaknesses-and-opportunities-in-the-global-health-system
#20
Suerie Moon, John-Arne Røttingen, Julio Frenk
Since at least the 1990s, there has been growing recognition that societies need global public goods (GPGs) in order to protect and promote public health. While the term GPG is sometimes used loosely to denote that which is 'good' for the global public, we restrict our use of the term to its technical definition (goods that are non-excludable and non-rival in consumption) for its useful analytical clarity. Examples of important GPGs for health include standards and guidelines, research on the causes and treatment of disease, and comparative evidence and analysis...
April 2017: Health Economics, Policy, and Law
journal
journal
41056
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"